Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's a joke?
I got tired of waiting for these people ... 3 years and they have not exceeded 15 million. Legalization is not on the horizon yet and they are not doing anything else. In my case, I no longer have positions in CRON. In the future, if I see something that encourages me again, I will buy again. Just look at the Instagram followers of Lord Jones and Happy Dance ... a very small captive market and nothing new.
The "Coming Soon" takes 3 years ... and continues ... the truth is that every time I lose more interest ...
In my humble opinion, there are two clear games. The massive gambling, which will radically change CRON's income and goes through legalization in the US. I firmly believe that Altria and Cronos have everything ready for when that happens. They will enter the market en masse, but it depends on legalization and that nobody knows when it will happen. The other game is the most passive but safe and constant, and it is through Happy Dance, Lord Jones and PharmaCann. Happy dance will launch new product.
https://www.glossy.co/beauty/kristen-bells-cbd-brand-happy-dance-moves-into-skin-care/
Yes, I agree with you!
Yeah! Is coming! very fast! Go CRON!
Awesone article! Thank you.
Very good article. Thanks for sharing.
Totally agree with you.
"In Cohn, Cronos gets a lawyer well-versed in the federal and state claims substantiation protocols required of consumer products companies that lean on advertising and marketing campaigns to expand product lines."
"Cohn previously worked at beauty products company Atlantic Coast Brands and vitamin manufacturer Nature’s Bounty Co., in-house jobs he took after serving as a partner at now-defunct LeClairRyan and of counsel at Venable."
Source: https://news.bloomberglaw.com/us-law-week/canadian-pot-producer-adds-avon-legal-chief-for-regulatory-role
Other aspects that seem relevant to me:
- CRONOS completed a shipment of Cannabis from Colombia USA with permission from the DEA. Why didn't they send it to Canada? In my opinion, they are testing the import to the US.
- Sales have clearly fallen due to COVID. All producers have reported declines of between 20% and 30% in sales of recreational products in Canada. Most of the stores are located in the center of the cities, the difficulty to move makes people resort to the black market and that the stores do not carry out restocking of inventories.
- Companies like ACB are opting for PREMIUM products as they have realized that it is difficult to compete with conventional products that are sold on the black market for half the price duty free. This is something that CRONOS has been doing since the beginning.
- The only thing that grew was the medicinal market and CRONOS has been betting on that market from the beginning.
CRONOS has been, by far, the company with the best vision of the business since its inception. Expansion has been slow but steady. The Lord Jones purchase has been widely criticized, but it opened the door to the US market, and that is invaluable.
On the other hand, COVID delayed the plans for a year, which cannot be lost sight of.
The fundamentals are the same:
- CRONOS has money for many quarters.
-It has an agreement with Ginkgo that will allow it to manufacture products at a very low cost (this gives it an incredible competitive advantage).
-The thesis that you will not be able to sell in the US if it is legalized falls when we know that you can buy an MSO at any time and enter.
-It has Lord Jones and Happy Dance selling in the United States (CRONOS is already within the United States).
-It has the business in Israel and the possibility of selling in the next recreational market that opens.
-He has several patents.
CRONOS is much better than 2 years ago and its shares are worth the same, the price of $ 7 is a gift. Those of us who have enough time here have seen this rise and fall over and over again. So the price and what has happened these weeks have nothing to do with the fundamentals, but with the news. In my opinion, these stocks go up only because of trading and news, not fundamentals, because the sell is horrible or very good.
Let's not lose sight of the fact that the shares of Tilray, ACB and Aphria were once worth less than CRONOS, but the valuation of CRONOS has always been the most stable. CRONOS is attractive to those of us who know it, but most do not understand this company and that is why the price is maintained. At $ 7 are the people who really believe in this company, up or down is speculation. For me, this company has a valuation of at least $ 15, but that's just my opinion. And that's why I'm still here.
I really appreciate your contributions. Unfortunately it seems that there are other people who have no other job than to come here to talk nonsense. Fortunately I can ignore them.
Go CRON!
That's right, good progress. Slow, but progress. I believe that it becomes more and more a long game. After a read, it looks like they will launch the products in Canada, test there and then go to the US. They did not say anything about the recreational market in Israel or the recreational market in Mexico that at this rate will come first than the US market. I see them increasingly focused on medicinal and beauty products more than recreational, even so it is rare given the investment of Altria that surely the recreational market is pursuing, however they have not said which is the strategy to follow to enter the US. I really think they will be sitting on the pile of money until the US market is legalized and then we will hear what they will do. But for that to begin it may take another year. I do not see interest in increasing sales immediately. Most people find the sales value horrible, but it is clear to me that they have no interest in increasing it immediately. I believe that right now Cronos is a company with immense potential that we will only see when the US is legalized. I think there are many more markets and more places to invest and develop, but that seems to be not the strategy to follow. On the other hand, I think that we will soon see if parallel lines of business will open that we are not aware of with the fermentation and the agreement with Ginkgo. It is my humble opinion.
Well, I don't see a problem with that, buy Altria. Many people do. It all depends on what your investment strategy is.
Altria, just one trick? I do not believe it
If that were not possible, they would not seek to patent the process ... On the other hand, it is not about who grows more product, come on, that is done by anyone at home. It is about doing it at competitive prices with high quality margins and having an important distribution network and agreements in many places. You can have a large quantity of product and have nowhere to sell it ... that's what has happened in Canada so far. On the other hand, to combat illegal trade, prices must go down and that is only done with technology. For me Cronos is a scientist and the rest are farmers.
Patent:
https://twitter.com/Matt__Connors/status/1374021019225194497/photo/1
I still believe that the US market is a very small part of this whole business ... and just the recreational business. I believe that CRON is a company with a technological and international profile and whose most valuable asset is synthetic cannabinoids. Consequently, it has nothing to do with its peers in strategy and growth possibilities.
So what do we have to believe here? Which Altria threw the money when buying CRON? Now there is the thesis that MSO's will be the only ones that will be able to enter the US market and that the money will not go to Canadian LP's
Go CRON!
Happy Dance available in ULTA!
https://www.ulta.com/cbd-head-toe-coconut-melt?productId=pimprod2023119
I just hope that Cronos sees the markets outside the US ... There is a lot of growth potential in the rest of the world.
https://www.nbcnews.com/news/world/mexico-moves-closer-becoming-world-s-largest-legal-cannabis-market-n1259519
LOL neither
Yes. Patience...
Yes, it's cheap, time to buy more. Imho.
The reason I am not selling this stock. I think this is more important than the US market and Altria's investment. I think this could push the stock above $ 20 by Q1 2022. Of course it's just an opinion, I don't have a crystal ball to know.
"Yeah. Yeah, we currently expect to achieve commercialization by the third quarter of 2021. And we're -- as you said, we -- as I said in my opening remarks, we really are prioritizing the rare cannabinoids because we believe that's going to be a greater ability to innovate and provide consumers with differentiated products. And so, we're really excited about that.
I don't want to go on the exact products right now, but we're well on our way. So, again, we are on track, and we're feeling very good about it. And obviously, the rare cannabinoids offer some really unique differentiated consumer products and benefits that we obviously want to focus on."
Back to February 1 and still no earnings reported. We will return to a digit ...
"There's no marijuana friendly banking language in the 1.9 stimulus proposal pot stocks going to have a rough week."
taken from someone on twitter. who knows about this?
ER Friday 26 before open market... Good Luck to everyone.